Effects of Combined Concurrent Training with Cricket Peptide Supplementation on Cardiometabolic and Functional Fitness Parameters in Older Adults

Phase 2

Completed

• Conditions: Older adults; aging; combined exercise; physical fitness; protein supplementation; quality of life

• Registration Number: TCTR20230208010
• Lead Sponsor: Graduate School, Kasetsart University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2022-07-04
• Study Start: 2023-02-08
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

1. Males and females aged 55 and over
2. Body mass index between 18.5-27.5 kg/m2
3.Systolic blood pressure equal to or greater than 130 mmHg and/or diastolic blood pressure equal to or greater than 85 mmHg
4. Availability to attend the exercise program three times a week

Exclusion Criteria

1. The allergic reaction with crustaceans
2. Current smoking
3. Unstable and/or uncontrolled cardiovascular diseases
4. Musculoskeletal problems to physical exercise
5. Severe visual impairment
6. Kidneys or livers disease

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Body composition before and after 12 weeks of intervention Dual-energy X-ray,Physical function before and after 12 weeks of intervention Senior fitness test,Muscle strength before and after 12 weeks of intervention 1RM of bench press and leg press,Insulin-like growth factor-1 before and after 12 weeks of intervention IRMA kits ,Fasting blood glucose before and after 12 weeks of intervention automated analyzer ,Plasma insulin concentration before and after 12 weeks of intervention commercial radioimmunoassay kits ,Lipid profiles before and after 12 weeks of intervention automated colorimetric assay ,Serum hs-CRP concentration before and after 12 weeks of intervention high-sensitivity immunoturbidimetric assay ,Blood pressure before and after 12 weeks of intervention automated sphygmomanometer,Arterial stiffness before and after 12 weeks of intervention pulse wave velocity,Heart rate variability before and after 12 weeks of intervention eMotion Faros

Secondary Outcome Measures

Name	Time	Method
Quality of life before and after 12 weeks of intervention World Health Organization Quality of Life Brief Version Thai